TY - JOUR T1 - Evaluation of a Rapid Implementation of Telemedicine for Delivery of Obstetric Care During the COVID-19 Pandemic JF - medRxiv DO - 10.1101/2021.05.19.21257311 SP - 2021.05.19.21257311 AU - Chinyere N. Reid AU - Jennifer Marshall AU - Kimberly Fryer Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/22/2021.05.19.21257311.abstract N2 - Objective The aim of this evaluation was to assess the rapid implementation of obstetric telemedicine during the COVID-19 pandemic using the Consolidated Framework in Implementation Research (CFIR) evaluation framework.Study Design Following one month of telemedicine implementation, obstetric providers at the University of South Florida clinic completed qualitative surveys and in-depth interviews about the implementation of obstetric telemedicine in the clinic guided by the CFIR evaluation framework.Results Overall, providers considered obstetric telemedicine comparable to traditional in-person clinic visits and acknowledged that they were adequately prepared for the telemedicine implementation. Advantages included the simplicity of implementation, reduced exposure to COVID-19 infection, and convenience factors. Although obstetric telemedicine mostly met patient needs, a lack of access to at-home monitoring devices, physical examinations, reliable internet service, and privacy concerns posed as barriers.Conclusion The implementation of the obstetric telemedicine care model was deemed a favorable, safe alternative option for patients during the COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementInternal Seed Grant from University of South FloridaAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was deemed except by the University of South Florida Institutional Review BoardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data available only with Data Use Agreement with University of South Florida ER -